ArticleMethods in enzymology2025
Discovery of bacterial terpenoids by genome mining.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Terpenoid natural products are widely distributed in nature and possess diverse molecular structures that bestow remarkable biological activities. A tremendous number of terpenoids have been isolated from plants and fungi; however, traditional natural product discovery methods currently face challenges in the identification of new terpenoids due to the enormous library of known compounds. The advent of next-generation sequencing and synthetic biology technologies began the era of genome mining and natural product discovery efforts, including those for terpenoids, have rightfully been stimulated. Data in genomic repositories reveal the presence of numerous putative terpene synthase genes in bacteria, highlighting an untapped potential for terpenoid biosynthesis in these microorganisms. To harness this potential, here we outline genome mining methods for identifying novel terpene synthases and discovering terpenoid natural products from bacteria. The continued identification and development of terpenoids holds promise for their application as drugs and in various industrial and commercial processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.